Galenika donates EUR 400,000 to the national fight against COVID 19

04/21/2020   •   Customer news
Galenika donates EUR 400,000 to the national fight against COVID 19

Galenika a.d. Belgrade produced and placed 372,000 tablets of the drug Hydroxychloroquine Sulfate on the disposal of the Government of the Republic of Serbia. The value of the manufactured medicines, which Galenika will donate to the health system of the Republic of Serbia, is 400.000 euros. Hydroxychloroquine production is completed today and complete quantities will be handed over to the Republic Health Insurance Fund in the coming days. The technology used in the production of Hydroxychloroquine was provided by  EMS company from Brazil which is the owner of Galenika a.d. Belgrade since November 2017. Our colleagues from the parent company confirmed the adequacy of technological conditions, expertise and ability of Galenika employees to produce this, in the world during the pandemic of COVID 19, a highly sought after medicine by EMS technology.

“We share the concerns of the citizens of the Republic of Serbia in this difficult time. We are working hard to ensure continuity of supply and to provide security for patients and consumers by providing sufficient quantities of our products. Hydroxychloroquine production and donation is our contribution to the common struggle of Serbian citizens and an expression of our desire to support the efforts of the Serbian health system as a socially responsible company, ”said Ricardo Vian Marques, General Manager of Galenika a.d Belgrade.

Last month, EMS from Brazil, initiated the initiation of clinical trials of Hydroxychloroquine in the treatment of COVID 19, which has so far proven effective in therapeutic combination with other drugs. As a result, Galenika immediately offered her knowledge and resources to actively support the national fight against COVID 19 in Serbia.